Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Roman

Showing results (361-370 of 387) with videos related to

Pageof 39
Sort By:
Journal of the American Geriatrics Society|July 29, 2010
The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homesSherrie L Aspinall, Xinhua Zhao, Steven M Handler, et al.
Plos One|December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancerMihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Gynecologic Oncology|April 20, 2023
Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancerJocelyn Garcia-Sayre, Yvonne G Lin, Koji Matsuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapyMory Nouriani, Afshin Bahador, Jonathan S Berek, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2024
Subchronic elevation in ambient temperature drives alterations to the sperm epigenome and accelerates early embryonic development in miceNatalie Trigg, John E Schjenken, Jacinta H Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 25, 2018
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian CancerTatyana V Gorodnova, Khristina B Kotiv, Alexandr O Ivantsov, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Gynecologic Oncology|July 30, 2020
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trialAna Oaknin, Claire F Friedman, Lynda D Roman, et al.
Gynecologic Oncology|September 4, 2025
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocolKoji Matsuo, Danielle M Enserro, Jason D Wright, et al.
Communications Biology|October 29, 2025
Exposure of mice to environmentally relevant per- and polyfluoroalkyl substances (PFAS) alters the sperm epigenomeLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Pageof 39

Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
Journal of the American Geriatrics Society|July 29, 2010
The quality of warfarin prescribing and monitoring in Veterans Affairs nursing homesSherrie L Aspinall, Xinhua Zhao, Steven M Handler, et al.
Plos One|December 14, 2011
Genome-scale screen for DNA methylation-based detection markers for ovarian cancerMihaela Campan, Melissa Moffitt, Sahar Houshdaran, et al.
Gynecologic Oncology|April 20, 2023
Two staged phase II clinical trial of Eribulin monotherapy in advanced or recurrent cervical cancerJocelyn Garcia-Sayre, Yvonne G Lin, Koji Matsuo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2004
Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapyMory Nouriani, Afshin Bahador, Jonathan S Berek, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 11, 2024
Subchronic elevation in ambient temperature drives alterations to the sperm epigenome and accelerates early embryonic development in miceNatalie Trigg, John E Schjenken, Jacinta H Martin, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|September 25, 2018
Efficacy of Neoadjuvant Therapy With Cisplatin Plus Mitomycin C in BRCA1-Mutated Ovarian CancerTatyana V Gorodnova, Khristina B Kotiv, Alexandr O Ivantsov, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 28, 2015
Population distribution of lifetime risk of ovarian cancer in the United StatesCeleste Leigh Pearce, Daniel O Stram, Roberta B Ness, et al.
Gynecologic Oncology|July 30, 2020
Neratinib in patients with HER2-mutant, metastatic cervical cancer: Findings from the phase 2 SUMMIT basket trialAna Oaknin, Claire F Friedman, Lynda D Roman, et al.
Gynecologic Oncology|September 4, 2025
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocolKoji Matsuo, Danielle M Enserro, Jason D Wright, et al.
Communications Biology|October 29, 2025
Exposure of mice to environmentally relevant per- and polyfluoroalkyl substances (PFAS) alters the sperm epigenomeLeah Gillespie, Jacinta H Martin, Amanda L Anderson, et al.
Pageof 39